A Matter of Life or Death: Productively Infected and Bystander CD4 T Cells in Early HIV Infection. 2020

Dechao Cao, and Sushant Khanal, and Ling Wang, and Zhengke Li, and Juan Zhao, and Lam Nhat Nguyen, and Lam Ngoc Thao Nguyen, and Xindi Dang, and Madison Schank, and Bal Krishna Chand Thakuri, and Jinyu Zhang, and Zeyuan Lu, and Xiao Y Wu, and Zheng D Morrison, and Mohamed El Gazzar, and Shunbin Ning, and Jonathan P Moorman, and Zhi Q Yao
Center of Excellence for Inflammation, Infectious Disease and Immunity, James H. Quillen College of Medicine, East Tennessee State University, Johnson City, TN, United States.

CD4 T cell death or survival following initial HIV infection is crucial for the development of viral reservoirs and latent infection, making its evaluation critical in devising strategies for HIV cure. Here we infected primary CD4 T cells with a wild-type HIV-1 and investigated the death and survival mechanisms in productively infected and bystander cells during early HIV infection. We found that HIV-infected cells exhibited increased programmed cell death, such as apoptosis, pyroptosis, and ferroptosis, than uninfected cells. However, productively infected (p24+) cells and bystander (p24-) cells displayed different patterns of cell death due to differential expression of pro-/anti-apoptotic proteins and signaling molecules. Cell death was triggered by an aberrant DNA damage response (DDR), as evidenced by increases in γH2AX levels, which inversely correlated with telomere length and telomerase levels during HIV infection. Mechanistically, HIV-infected cells exhibited a gradual shortening of telomeres following infection. Notably, p24+ cells had longer telomeres compared to p24- cells, and telomere length positively correlated with the telomerase, pAKT, and pATM expressions in HIV-infected CD4 T cells. Importantly, blockade of viral entry attenuated the HIV-induced inhibition of telomerase, pAKT, and pATM as well as the associated telomere erosion and cell death. Moreover, ATM inhibition promoted survival of HIV-infected CD4 T cells, especially p24+ cells, and rescued telomerase and AKT activities by inhibiting cell activation, HIV infection, and DDR. These results indicate that productively infected and bystander CD4 T cells employ different mechanisms for their survival and death, suggesting a possible pro-survival, pro-reservoir mechanism during early HIV infection.

UI MeSH Term Description Entries
D008297 Male Males
D002470 Cell Survival The span of viability of a cell characterized by the capacity to perform certain functions such as metabolism, growth, reproduction, some form of responsiveness, and adaptability. Cell Viability,Cell Viabilities,Survival, Cell,Viabilities, Cell,Viability, Cell
D004249 DNA Damage Injuries to DNA that introduce deviations from its normal, intact structure and which may, if left unrepaired, result in a MUTATION or a block of DNA REPLICATION. These deviations may be caused by physical or chemical agents and occur by natural or unnatural, introduced circumstances. They include the introduction of illegitimate bases during replication or by deamination or other modification of bases; the loss of a base from the DNA backbone leaving an abasic site; single-strand breaks; double strand breaks; and intrastrand (PYRIMIDINE DIMERS) or interstrand crosslinking. Damage can often be repaired (DNA REPAIR). If the damage is extensive, it can induce APOPTOSIS. DNA Injury,DNA Lesion,DNA Lesions,Genotoxic Stress,Stress, Genotoxic,Injury, DNA,DNA Injuries
D005260 Female Females
D006657 Histones Small chromosomal proteins (approx 12-20 kD) possessing an open, unfolded structure and attached to the DNA in cell nuclei by ionic linkages. Classification into the various types (designated histone I, histone II, etc.) is based on the relative amounts of arginine and lysine in each. Histone,Histone H1,Histone H1(s),Histone H2a,Histone H2b,Histone H3,Histone H3.3,Histone H4,Histone H5,Histone H7
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000079404 Regulated Cell Death Genetically encoded mechanisms in multicellular and unicellular eukaryotes that function to eliminate cells that are superfluous either during development, or to maintain tissue and organism homeostasis; and cells that are irreversibly damaged, abnormal, and/or potentially harmful. Cell Death, Regulated
D015496 CD4-Positive T-Lymphocytes A critical subpopulation of T-lymphocytes involved in the induction of most immunological functions. The HIV virus has selective tropism for the T4 cell which expresses the CD4 phenotypic marker, a receptor for HIV. In fact, the key element in the profound immunosuppression seen in HIV infection is the depletion of this subset of T-lymphocytes. T4 Cells,T4 Lymphocytes,CD4-Positive Lymphocytes,CD4 Positive T Lymphocytes,CD4-Positive Lymphocyte,CD4-Positive T-Lymphocyte,Lymphocyte, CD4-Positive,Lymphocytes, CD4-Positive,T-Lymphocyte, CD4-Positive,T-Lymphocytes, CD4-Positive,T4 Cell,T4 Lymphocyte
D015497 HIV-1 The type species of LENTIVIRUS and the etiologic agent of AIDS. It is characterized by its cytopathic effect and affinity for the T4-lymphocyte. Human immunodeficiency virus 1,HIV-I,Human Immunodeficiency Virus Type 1,Immunodeficiency Virus Type 1, Human
D015658 HIV Infections Includes the spectrum of human immunodeficiency virus infections that range from asymptomatic seropositivity, thru AIDS-related complex (ARC), to acquired immunodeficiency syndrome (AIDS). HTLV-III Infections,HTLV-III-LAV Infections,T-Lymphotropic Virus Type III Infections, Human,HIV Coinfection,Coinfection, HIV,Coinfections, HIV,HIV Coinfections,HIV Infection,HTLV III Infections,HTLV III LAV Infections,HTLV-III Infection,HTLV-III-LAV Infection,Infection, HIV,Infection, HTLV-III,Infection, HTLV-III-LAV,Infections, HIV,Infections, HTLV-III,Infections, HTLV-III-LAV,T Lymphotropic Virus Type III Infections, Human

Related Publications

Dechao Cao, and Sushant Khanal, and Ling Wang, and Zhengke Li, and Juan Zhao, and Lam Nhat Nguyen, and Lam Ngoc Thao Nguyen, and Xindi Dang, and Madison Schank, and Bal Krishna Chand Thakuri, and Jinyu Zhang, and Zeyuan Lu, and Xiao Y Wu, and Zheng D Morrison, and Mohamed El Gazzar, and Shunbin Ning, and Jonathan P Moorman, and Zhi Q Yao
June 2004, Blood,
Dechao Cao, and Sushant Khanal, and Ling Wang, and Zhengke Li, and Juan Zhao, and Lam Nhat Nguyen, and Lam Ngoc Thao Nguyen, and Xindi Dang, and Madison Schank, and Bal Krishna Chand Thakuri, and Jinyu Zhang, and Zeyuan Lu, and Xiao Y Wu, and Zheng D Morrison, and Mohamed El Gazzar, and Shunbin Ning, and Jonathan P Moorman, and Zhi Q Yao
October 2011, Journal of virology,
Dechao Cao, and Sushant Khanal, and Ling Wang, and Zhengke Li, and Juan Zhao, and Lam Nhat Nguyen, and Lam Ngoc Thao Nguyen, and Xindi Dang, and Madison Schank, and Bal Krishna Chand Thakuri, and Jinyu Zhang, and Zeyuan Lu, and Xiao Y Wu, and Zheng D Morrison, and Mohamed El Gazzar, and Shunbin Ning, and Jonathan P Moorman, and Zhi Q Yao
May 1992, Clinical and experimental immunology,
Dechao Cao, and Sushant Khanal, and Ling Wang, and Zhengke Li, and Juan Zhao, and Lam Nhat Nguyen, and Lam Ngoc Thao Nguyen, and Xindi Dang, and Madison Schank, and Bal Krishna Chand Thakuri, and Jinyu Zhang, and Zeyuan Lu, and Xiao Y Wu, and Zheng D Morrison, and Mohamed El Gazzar, and Shunbin Ning, and Jonathan P Moorman, and Zhi Q Yao
February 2014, European journal of immunology,
Dechao Cao, and Sushant Khanal, and Ling Wang, and Zhengke Li, and Juan Zhao, and Lam Nhat Nguyen, and Lam Ngoc Thao Nguyen, and Xindi Dang, and Madison Schank, and Bal Krishna Chand Thakuri, and Jinyu Zhang, and Zeyuan Lu, and Xiao Y Wu, and Zheng D Morrison, and Mohamed El Gazzar, and Shunbin Ning, and Jonathan P Moorman, and Zhi Q Yao
February 1995, Nature medicine,
Dechao Cao, and Sushant Khanal, and Ling Wang, and Zhengke Li, and Juan Zhao, and Lam Nhat Nguyen, and Lam Ngoc Thao Nguyen, and Xindi Dang, and Madison Schank, and Bal Krishna Chand Thakuri, and Jinyu Zhang, and Zeyuan Lu, and Xiao Y Wu, and Zheng D Morrison, and Mohamed El Gazzar, and Shunbin Ning, and Jonathan P Moorman, and Zhi Q Yao
December 1997, Blood,
Dechao Cao, and Sushant Khanal, and Ling Wang, and Zhengke Li, and Juan Zhao, and Lam Nhat Nguyen, and Lam Ngoc Thao Nguyen, and Xindi Dang, and Madison Schank, and Bal Krishna Chand Thakuri, and Jinyu Zhang, and Zeyuan Lu, and Xiao Y Wu, and Zheng D Morrison, and Mohamed El Gazzar, and Shunbin Ning, and Jonathan P Moorman, and Zhi Q Yao
January 2013, PLoS pathogens,
Dechao Cao, and Sushant Khanal, and Ling Wang, and Zhengke Li, and Juan Zhao, and Lam Nhat Nguyen, and Lam Ngoc Thao Nguyen, and Xindi Dang, and Madison Schank, and Bal Krishna Chand Thakuri, and Jinyu Zhang, and Zeyuan Lu, and Xiao Y Wu, and Zheng D Morrison, and Mohamed El Gazzar, and Shunbin Ning, and Jonathan P Moorman, and Zhi Q Yao
July 2013, Retrovirology,
Dechao Cao, and Sushant Khanal, and Ling Wang, and Zhengke Li, and Juan Zhao, and Lam Nhat Nguyen, and Lam Ngoc Thao Nguyen, and Xindi Dang, and Madison Schank, and Bal Krishna Chand Thakuri, and Jinyu Zhang, and Zeyuan Lu, and Xiao Y Wu, and Zheng D Morrison, and Mohamed El Gazzar, and Shunbin Ning, and Jonathan P Moorman, and Zhi Q Yao
March 2003, AIDS research and human retroviruses,
Dechao Cao, and Sushant Khanal, and Ling Wang, and Zhengke Li, and Juan Zhao, and Lam Nhat Nguyen, and Lam Ngoc Thao Nguyen, and Xindi Dang, and Madison Schank, and Bal Krishna Chand Thakuri, and Jinyu Zhang, and Zeyuan Lu, and Xiao Y Wu, and Zheng D Morrison, and Mohamed El Gazzar, and Shunbin Ning, and Jonathan P Moorman, and Zhi Q Yao
March 1997, Journal of immunology (Baltimore, Md. : 1950),
Copied contents to your clipboard!